STOUGHTON, Mass. (AP) _ Collegium Pharmaceutical Inc. (COLL) on Wednesday reported a loss of $6.1 million in its third quarter.
The Stoughton, Massachusetts-based company said it had a loss of 18 cents per share.
The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.
The specialty pharmaceutical company posted revenue of $72.9 million in the period, also falling short of Street forecasts. Six analysts surveyed by Zacks expected $74.2 million.
Collegium Pharmaceutical shares have decreased 20% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $13.70, a drop of 12% in the last 12 months.